Introduction {#sec1-1}
============

Superficial and visible veins in the face can represent an aesthetic concern. Reticular blue veins occur most frequently in the lower eyelids toward the lateral portion of the orbit. These vascular structures around the eyelids are more visible because of the specific anatomical characteristics of the region with no or limited subcutaneous fat beneath the thin skin. They become more visible in patients with fair skin, after weight loss and during ageing. The veins are asymptomatic and the main concern is related to the aesthetic aspect. The desire of the patient is to eliminate the appearance of these dilated and protruding reticular veins. The management of periorbital veins is part of periorbital rejuvenation \[[@ref1]\].

Despite all risks and side effects sclerotherapy using sodium tetradecyl sulfate, transection and cautery, extraction (phlebectomy) and electro cauterization remained during a long time the main treatment options \[[@ref2]\]. The safety profile of certain techniques, such as sclerotherapy, is questionable in this region where complications related to vision would be catastrophic. Currently, the most effective and safe method for treating these cosmetically unattractive veins in the periocular region is the laser \[[@ref3]\].

Case report {#sec1-2}
===========

We present a case of a 41-year-old female patient with a reticular vein in the lower lid (blue periocular lower eyelid vein, patient skin photo type Fitzpatrick II) ([Fig. 1 a, b](#F1){ref-type="fig"}). No previous treatment was done. After a clinical examination, she was treated with three consecutive sessions of laser. The parameters of the long-pulsed 1064 nm neodymium-doped yttrium aluminium garnet (Nd: YAG) laser were as follows: fluence ranging from 100 to 125 J/cm2 with a 2.5 mm and 4.0 mm spot size. The pulse width ranged from 3 msec to 15 msec (Synchro and Smartepil, Deka, Italy).

![a, b - Reticular vein in lower eyelid; c, d Result 8 years after laser treatment](OAMJMS-6-58-g001){#F1}

The sessions were performed monthly. No topical or local anaesthesia was used. The eyes were protected with specific eye wear. Cryogen spray was used before and immediately after laser shot. Erythema and mild oedema occurred. No other side effects were observed. The vein was effectively treated and absorbed after the third session.

The patient was satisfied with the result and returned for consultation 8 years later for another reason ([Fig. 1 c, d](#F1){ref-type="fig"}). The affected region previously treated with the laser presented no skin pigmentation and no evidence of reticular vein recurrence.

Discussion {#sec1-3}
==========

Laser treatment of vascular structures is dependent on the selected wavelength. The pulse width of the laser must be shorter than the target's thermal relaxation time, which is the time required for the target to lose half of its peak temperature following irradiation. And finally, the fluence has to be sufficient to achieve the desired tissue response within an appropriate time interval \[[@ref4]\].

Laser treatment of facial veins or telangiectasia has been reported with different sources of laser including the diode, potassium titanyl phosphate (KTP), copper-bromide, Nd: YAG lasers and pulsed dye lasers among other. Treatment aims to achieve blanching without causing a skin or burn lesion with a consequent resorption of the vein \[[@ref5]\]\[[@ref6]\]\[[@ref7]\].

Thread-like constriction is the desired treatment endpoint of the vascular laser. This is a consequence of complete vascular occlusion by a thrombus. Cavitation can cause haemorrhage when a thrombus fails to occlude the vessel completely \[[@ref8]\]. In vitro experiment found that vessel constriction was due to the constriction of thrombus induced by laser irradiation. The theoretical investigation revealed that the mechanism for the effective reduction of energy density by multi-pulse Nd: YAG laser was due to enhanced light absorption of the blood with thrombus formation \[[@ref9]\]\[[@ref10]\].

The long-pulsed Nd: YAG laser at 1064nm demonstrated to be a safe, simple, effective and fast treatment in the treatment of superficial vein in the eyelid \[[@ref11]\]\[[@ref12]\]\[[@ref13]\]. Eremia and Li (2002) were the first who reported on Nd: YAG laser in 8 patients with periorbital reticular veins. Their treatment parameters consisted of a fluence between 125-150 J/cm^2^ with a 6 mm spot size and pulse widths of 75-100 msec. They also employed cryogen spray like us. However, they did not report on the long-term outcome.

We used a smaller spot size of 4 mm with a much shorter pulse width between 3 to 15 msec. This has been recommended based on mathematical modelling of vascular response to laser irradiation. In general, for selective photothermolysis the laser pulse duration should be similar to the thermal relaxation time of targeted vessels (Anderson & Parrish 1983). For vessels with a diameter between 30 µm and 300 µm, a relaxation time between 1 to 100 msec has been calculated (Mordon & Bourg-Heckly 2016) \[[@ref14]\].

Here we report on the successful treatment of lower lid vein with a follow-up of 8 years. There was no relapse demonstrating the efficacy of Nd: YAG laser.
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